SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

September 16, 2013 08:35 ET

MyMedicalRecords Receives Canadian Online Medical Records Patent

LOS ANGELES, CA--(Marketwired - Sep 16, 2013) - MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"), today announced that it has received Canadian Patent Application No. 2,615,128 entitled "Method and System for Providing Online Medical Records," issued on September 10, 2013. The Canadian patent includes 40 claims including claims corresponding to those in U.S. Patent No. 8,301,466 which is already being asserted against The Walgreen Co. and numerous other companies in the U.S. (www.pacer.com). Additionally, and based on information contained in a recent article in Seeking Alpha (http://m.seekingalpha.com/article/1586342), MMR believes that Walgreens and others could be generating in excess of one billion dollars each per year using methods and systems contained in one of MMR's patents currently being asserted in suit. MMR's patent portfolio includes eight issued U.S. patents pertaining to electronic medical records, prescription management and personal health records (PHRs) covering inventions that provide methods and systems that allow patients access to, and control of, protected health information, amongst other things. The Canadian patent expands the scope of MMR's global patent portfolio, which with Mexico, now includes all of North America, as well as patents issued, pending and applied for in other countries of commercial interest including Australia, Singapore, New Zealand, Canada, Japan, Hong Kong, China, South Korea, Israel and various European nations. Additionally, MMR has retained the firm of Sydney-based Rockwell Olivier which has hired experts in preparation for upcoming meetings with representatives with the new Australian Government regarding settlement of claims MMR may have in Australia.

MMR is also in the final stages of negotiating an agreement with a large investment fund specializing in financing the enforcement and licensing of global intellectual property rights using non-dilutive structured partnerships. This would maximize MMR's ability to exploit its global health IT patent portfolio and also the biotech assets it acquired through a reverse merger with Favrille, Inc. in January 2009. 

According to Robert H. Lorsch, MMRGlobal CEO, "With patents in 13 countries, a joint venture agreement in China, and Meaningful Use Stage 2 being implemented here in the U.S., MMR is uniquely positioned to be the go anywhere global brand. Over the past several months, MMR has been contacted by numerous hedge funds and other investors that specialize in the exploitation of patents and intellectual property. These funds form structured partnerships that participate in the flow of royalties from a group or bucket of patents in different countries. With all of North America at our fingertips, we believe now is the time to avail MMR to that type of strategic partnership."

The Canadian patent is directed toward methods for providing users with the ability to access and collect health records and covers the exchange of protected health information to and from patients, doctors, pharmacies, insurance providers and other healthcare professionals in forms including, but not limited to, email, text, phone, facsimile and web-based portals.

MMR is a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions, and MMRPro document management and imaging systems for healthcare professionals. In less than two weeks, millions of American citizens will be able to start signing up for programs under Obamacare, which will rely on health IT and online medical records to deliver on cost savings through better coordination of care. Additionally, under the HITECH Act, Stage 2 Meaningful Use requirements mandate that patients have online access to their protected health information through a Personal Health Record or other form of patient portal by 2014.

About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of the Company's products and services at www.mmrtheater.com.

Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including, without limitation, potential intellectual property enforcement actions, infringement claims, litigation or licenses, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual outcomes of intellectual property enforcement actions, infringement claims, litigation or licensing transactions, results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes to Meaningful Use, and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

Contact Information